Bone-marrow transplantation in aspartylglucosaminuria

Lancet

Volumn 349, Issue 9062, 1997, Pages 1366-1367

  Autti, T ^a   Santavuori, P ^b   Raininko, R ^b   Rerdund, M ^b   Rapola, J ^b   Saarinen Pihkala, U ^b  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASPARTYLGLYCOSAMINURIA; CASE REPORT; CONTROLLED STUDY; GRAFT SURVIVAL; HUMAN; LYSOSOME STORAGE DISEASE; MYELINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030912028     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63202-3     Document Type: Article

References (5)

1. Haltia M, Palo J, Autio S. Aspartylglycosaminuria: a generalized storage disease. Morphological and histochemical studies. Acta Neuropathol 1975; 31: 243-55.
2. Arvio M. Follow-up in patients with aspartylglucosaminuria. Part I. The course of intellectual functions. Acta Paediatr 1993; 82: 469-71.
3. Autti T, Raininko R, Haltia M, et al. Aspartylglucosaminuria: radiological course of the disease with histopathologic correlation. J Child Neurol (in press).
4. Hoogerbrugge MP, Brouwe OF, Bordigoni P, et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. Lancet 1995; 345: 1398-402.
5. Autti T, Raininko R, Vanhanen S-L, Kallio M, Santavuori P. MRI of the normal brain from early childhood to middle age. II. Age dependence of signal intensity changes on T2-weighted images. Neuroradiology 1994; 36: 649-51.